Clinical and epidemiological characteristics of pediatric patients with positive serology for Mycoplasma pneumoniae, treated in the third level hospital from 2006 to 2008
Main Article Content
Objective: To describe demographic, clinical, laboratory, and treatment characteristics of pediatric-age patients with positive serology for M. pneumoniae diagnosed at the Pablo Tobón Uribe Hospital (HPTU) during the 2006-2008 period.
Materials and methods: Observational, retrospective study, which describes the demographic, clinical, laboratory, and treatment characteristics of patients from 1 month to 14 years of age with positive IgM for M. pneumoniae seen at HPTU during September 2006 and November 2008.
Results: We reviewed 305 clinical charts of patients with positive IgM for M. pneumoniae. The average age was 5.15 years ± 3.62 SD. Cough (87.5%), fever (65.9%), rhinorrea (39.3%), and respiratory difficulty (38%) were the most frequent clinical findings. Extrapulmonary compromise was mainly manifested in the skin (12.8%), the central nervous system (CNS) (3.6%), and osteomuscular system (3.9%). Auscultation and thoracic X-ray were normal in 33.1% and 30.8% of the patients, respectively. Episodes of asthma exacerbation were related to infection by Mycoplasma in 35% of the cases. A total of 51% of the patients required hospitalization with an average stay of seven days. All the patients received antibiotic treatment; clarithromycin (75.8%) was the antibiotic of choice.
Conclusion: Infection by M. pneumoniae has a broad range of clinical manifestations, requiring a high index of clinical suspicion and an active search for extrapulmonary compromise given that in our realm there is no specific diagnostic method for the acute infection.
- Mycoplasma pneumonia
- Pneumonia
- Extrapulmonary manifestations
- Children
Sánchez-Vargas FM, Gómez-Duarte OG. Mycoplasmapneumoniae - an emerging extra-pulmonary pathogen. ClinMicrobiol Infect. 2008; 14: 105-17.2.Alves-Vervloet L, Christophe M, Moreira-Camargos PA.Infection by Mycoplasma pneumoniae and its importance asan etiological agent in childhood community-acquiredpneumonias. Braz J Infect Dis. 2007; 11: 507-14.3.Gendrel D, Biscardi S, Marc E, Moulin F, Iniguez JL, RaymondJ. Mycoplasma pneumoniae, community-acquired pneumoniaand asthma. Arch Pediatr. 2005; 12 (Suppl 1): S7-11.4.Matas L, Molinos S, Fernández G, González V, Ausina N.Diagnóstico serológico de las infecciones por Mycoplasmapneumoniae. Enferm Infecc Microbiol Clin. 2006; 24: 19-23.5.Espinosa-Gimeno A, Martínez-Alfaro E, Meseguer-Ruiz V,Solera-Santos J. Infección por Mycoplasma y Chlamydia.Medicine. 1998; 7: 3687-92.6.American Academy of Pediatrics. Mycoplasma pneumoniaeinfections. In: Pickering LK (ed.) Red Book: Report of theCommittee on Infectious Diseases. 2 7th ed. Elk Grove Village:American Academy of Pediatrics;2006. p. 441-3.7.Ferwerda A, Moll HA, de Groot R. Respiratory tract infectionsby Mycoplasma pneumoniae in children: a review of diagnosticand therapeutic measures. Eur J Pediatr. 2001; 160: 483-91.8.Bébéar CM. Pathogenesis and laboratory diagnosis ofMycoplasma pneumoniae infections. Arch Pediatr. 2008; 15:1253-6.9. Paul MA, García C, Vega-Briceño L. Infección porMycoplasma pneumoniae. Rev Neumol Pediatr [on line] 2007[date of access 19 June 2009]; 2: 140-46. URL available in:http://www.neumologia-pediatrica.cl10. Bologna R. Mycoplasma pneumoniae: lo que nos queda porconocer. Arch Argent Pediatr. 2008; 106: 3-5.11. Paul MA, Vega-Briceño L, Potin M, Ferrés M, Pulgar D,García C, et al. Características clínicas de la enfermedad
Colombia Médica Vol. 42 Nº 2, 2011 (Abril-Junio)respiratoria causada por Mycoplasma pneumoniae en niñoshospitalizados. Rev Chilena Infectol. 2009; 26: 343-9.12. Grunfeld de Viú J, Scapin JP, Alarcón M. Infección respira-toria por Mycoplasma pneumoniae en pediatría. Arch ArgentPediatr. 2006; 104: 412-5.13. Waites KB, Talkington D. Mycoplasma pneumoniae and itsrole as a human pathogen. Clin Microbiol Rev. 2004; 17: 697-728.14. Higashigawa M, Kawasaki Y, Yodoya N, Omori Y, NashidaY, Amemiya Y, et al. Prevalence of Mycoplasma IgM inchildren with lower respiratory tract illness. Pediatr Int. 2009;51: 684-6.15. Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G,Di Marco E, et al. Epidemiology and clinical features ofMycoplasma pneumoniae infection in children. Respir Med.2008; 102: 1762-8.16. Salas Mallea A. Infección por Mycoplasma pneumoniae enniños hospitalizados por neumonía. Rev Soc Bol Pediatr.2007; 46: 163-70.17. Hassan J, Irwin F, Dooley S, Connell J. Mycoplasmapneumoniae infection in a pediatric population: analysis ofsoluble immune markers as risk factors for asthma. HumImmunol. 2008; 69: 851-5.18. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinicalmanifestations, pathogenesis and laboratory detection ofMycoplasma pneumoniae infections. FEMS Microbiol Rev.2008; 32: 956-73.19. Garnier JM, Noël G, Retornaz K, Blanc P, Minodier P.Extrapulmonary infections due to Mycoplasma pneumoniae.Arch Pediatr. 2005; 12 (Suppl 1): S2-6.20. Othman N, Isaacs D, Daley AJ, Kesson AM. Mycoplasmapneumoniae infection in a clinical setting. Pediatr Int. 2008;50: 662-6.21. Dávila-Agüero G. Micoplasma en patología pulmonarpediátrica. Rev Peru Pediatr. 2007; 60: 101-4.22. Mc Cracken GH. Diagnosis and management of pneumonia inchildren. Pediatr Infect Dis J. 2000; 19: 924-8.23. Souliou E, Almasri M, Papa A, Theodoridou A. Diza E.Laboratory diagnosis of Mycoplasma pneumoniae respiratorytract infections in children. Eur J Clin Microbiol Infect Dis.2007; 26: 513-5.24. Loens K, Goossens H, Leven M. Acute respiratory infectiondue to Mycoplasma pneumoniae: current status of diagnosticmethod. Eur J Clin Microbiol Infect Dis. 2010; 29: 1055-69.25. Sánchez-Ruiz-Cabello J, Maldonado-Espinosa MJ, Rubio-Quevedo C, Rosales-Zabel JM, Pereira-Rodríguez MJ, Hol-gado-Carballo MA. Neumonía por Mycoplasma pneumoniaeen una zona básica de salud. An Esp Pediatr. 2001; 55: 108-12
Downloads
- Catalina María Vélez Echeverri, Lina María Serna-Higuita, Ana Katherina Serrano Gayubo, Carolina Ochoa-García, Luisa Rojas Rosas, Ana María Bedoya, Margarita Suárez, Catalina Hincapie, Adriana Henao, Diana Ortiz, Juan José Vanegas Ruiz, Jhon Jairo Zuleta, David Andrés Espinal, Resistance profile for pathogens causing urinary tract infection in a pediatric population, and antibiotic treatment response, at a university hospital 2010-2011 , Colombia Medica: Vol. 45 No. 1 (2014)
- Liliana Moreno, Luis Fernando Velasquez, Carlos Alberto Restrepo, Jose David Paulo, Jorge Hernando Donado, Marta Lucía Muñoz, John Jairo Aristizabal, Ocular trauma from land mines among soldiers treated at a University Hospital in Medellín, Colombia , Colombia Medica: Vol. 44 No. 4 (2013)
- Nathalia Vélez, Luz Stella López, Jorge Alberto Rivera, Abraham Chams Anturi, David Andrés Espinal, Currarino’s syndrome. A case report , Colombia Medica: Vol. 40 No. 2 (2009)
- Carlos Andrés Molina, Jorge Hernando Donado, Liliana María Vélez, Natalia Andrea Martínez, Ana Isabel Rivera, Uveitis in patients with diagnosis of seronegative spondyloarthropathies. Hospital Pablo Tobón Uribe, Medellín, Colombia. , Colombia Medica: Vol. 38 No. 4 (2007)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use